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Abstract
Background: Conjugated linoleic acid (CLA) has many well-documented beneficial physiological effects. Due to the
insufficient natural supply of CLA and low specificity of chemically produced CLA, an effective and isomer-specific
production process is required for medicinal and nutritional purposes.
Results: The linoleic acid isomerase gene from Propionibacterium acnes was expressed in Yarrowia lipolytica Polh.
Codon usage optimization of the PAI and multi-copy integration significantly improved the expression level of PAI
in Y. lipolytica. The percentage of trans-10, cis-12 CLA was six times higher in yeast carrying the codon-optimized
gene than in yeast carrying the native gene. In combination with multi-copy integration, the production yield was
raised to approximately 30-fold. The amount of trans-10, cis-12 CLA reached 5.9% of total fatty acid yield in
transformed Y. lipolytica.
Conclusions: This is the first report of production of trans-10, cis-12 CLA by the oleaginous yeast Y. lipolytica, using
glucose as the sole carbon source through expression of linoleic acid isomerase from Propionibacterium acnes.
Keywords: Conjugated linoleic acid, Linoleate isomerase, Codon optimization, Multi-copy integration,
Propionibacterium acnes, Yarrowia lipolytica
Background
Conjugated linoleic acid (CLA) is a generic term used to
describe a mixture of positional and geometric isomers
of linoleic acid (LA) with conjugated double bonds. In
the past three decades, CLA has attracted much atten-
tion because of its biologically beneficial functions. These
include anti-carcinogenic, anti-atherogenic, anti-diabetic,
anti-inflammatory and anti-obesity properties in animal
models and humans. To date, three CLA isomers have
been demonstrated to possess beneficial effects individu-
ally: cis-9, trans-11 CLA, trans-10, cis-12 CLA and
trans-9, trans-11 CLA. Different isomers have different
effects on metabolism and act through different cell sig-
naling pathways [1-3].
In nature, CLA isomers occur in meat and dairy products
derived from ruminants as a minor component of the lipid
fraction [4]. Today, CLA, as a dietary supplement,is gener-
ally made from the LA of safflower and sunflower oils
through alkaline isomerization in which additional func-
tionally undetermined isomers are formed simultaneously
[5,6]. Moreover, in the vast majority of the studies about
CLA effectiveness on human volunteers, CLA mixtures ra-
ther than pure isomers have been used for supplementation
and the results were often controversial. Therefore, to meet
the requirements for medicinal and nutritional purposes,
CLA isomers need to be biologically safe and highly spe-
cific. Biological production of CLA may be crucial to ad-
dress these issues. It is well known that LA isomerase
catalyzes the conversion of LA into CLA isomers. As early
as 1965, Tove and colleagues demonstrated the existence
of LA isomerase activity of producing cis-9, trans-11 CLA
from LA in anaerobic rumen bacterium Butyrivibrio fibri-
solvens [7]. So far, only three LA isomerases derived from
Lactobacillus reuteri, Clostridium sporogenes and Propioni-
bacterium acnes have been fully characterized. The first
two isomerases are cis-9, trans- 11-CLA-producing iso-
merases and the other is a trans-10, cis-12-CLA-producing
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(PAI) is the only LA isomerase with its crystal structure
being characterized [10], and had been expressed in Escher-
ichia. coli [11], Saccharomyces. cerevisiae, tobacco seed
[12], rice [13] and Lactococcus lactis successively [14].
Unlike other enzymes such as fatty acyl desaturase and
fatty acyl elongase, PAI use free fatty acids as the only
substrate. Therefore, neither phosphatidylcholine, nor
methyl-, CoA-, or triacylglycerol- esters of LA can be
accepted as substrates [12]. Unfortunately, the amount of
free fatty acid is low in most eukaryotic organisms, which
thus becomes the primary limiting factor for CLA
production by biological synthesis [12,13]. However, as
an exception, Y. lipolytica, an oleaginous yeast, is able to
accumulate significant quantities of free fatty acid within
the cell [15]. Moreover, it can accumulate large amount
of lipids (> 25% of cell dry weight) with a high proportion
of LA in the fatty acid composition [16]. Therefore, the
non-conventional oleaginous yeast Y. lipolytica was used
as a model in this study, to investigate the production of
trans-10, cis-12-CLA from endogenous LA by over-
expressing the functional LA isomerase from P. acnes.
Results
PAI gene codon optimization
As the codon usage of the native PAI sequence differs
from that preferred by Y. lipolytica,ade novo codon-
optimized version of the gene was designed and synthe-
sized. In this optimized version of the gene, 48% of all
codons were replaced by Y. lipolytica-favored codons,
and the AT/GC ratio was adjusted to that of the host.
The codon adaption index (CAI) was improved from
0.76 (natural sequence) to 0.91 (synthetic gene) (Figure 1).
Additionally, the Kozak element was added before the
first AUG codon to prevent the leaky scanning of the
ribosome. The translation product of the synthetic gene
had the same amino acid sequence as native PAI.T ot e s t
the effectiveness of codon optimization in the expression
of the PAI, both the native sequence (PAI) and the codon-
optimized sequence (oPAI) were employed for expression
in Y. lipolytica.
Construction of recombinant yeast strains
The mono-copy vector pINA1312 and the multi-copy
vector pINA1292 were used for PAI expression in Y.
lipolytica. pINA1312 contains the non-defective ura3d1
gene for mono-copy expression, while pINA1292 con-
tains the defective ura3d4 gene, which is required in
multiple copies to alleviate the uracil auxotrophy of the
host [17]. Transformants with the non-defective vectors
appeared on YNBD after 2-3 days of incubation, while
transformants with defective vectors were observed after
4-6 days of incubation. Single-colony isolates were
named according to strain, plasmid, gene and clone
number as follows: Polh-1312-PAI-1 represents strain
Polh, plasmid pINA1312, gene PAI and clone number 1.
Seven Polh-1312-PAI transformants, twelve Polh-1312-
oPAI transformants and thirteen Polh-1292-oPAI trans-
formants were picked randomly and confirmed to be all
positive by PCR analysis.
PAI copy numbers in Y. lipolytica transformants
The copy numbers of the integrated expression cassette
among multi-copy transformants were estimated using
the data obtained after RT-PCR analysis. Y. lipolytica
Polg was used as a control organism with a single copy
of both the URA3 and SUC2 target sequences. As
URA3 and oPAI coexisted in expression cassette, the
copy numbers of both genes were considered as equal.
Distribution of PAI copy numbers analyzed in 13 iso-
lated Polh-1292-oPAI transformants is shown in Figure 2.
For all the clones tested, copy numbers were in the
range of 6-24 copies, having average12-13 copies/cell.
The majority of the transformants (9 clones) contained
10-16 copies/cell. The highest copy number was 24 in
strain Polh-1292-oPAI-5.
Figure 1 Codon usage optimization of bacterial PAI gene for expression in Y. lipolytica. Shown is the distribution of codon usage
frequency along the coding sequence and the calculated codon adaptation index (CAI).
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The expression level of the recombinant PAI in these
yeast transformants was analyzed by Western blot using
specific polyclonal antibodies raised against the recom-
binant PAI from E. coli. The recombinant PAI was
present in all yeast transformants carrying oPAI with
molecular size at approximately 50 kDa (Figure 3b and
3c), which was consistent with the size of PAI. By com-
parison, the level of PAI expressed from the native PAI
was extremely low and could not be detected by Western
blot except for two transformants (Polh-1312-PAI-3 and
Polh-1312-PAI-4, respectively) (Figure 3a). It was further
observed that the level of PAI expression in multi-copy
Polh-1292-oPAI transformants was significantly greater
than that in the mono-copy oPAI transformants (Fig-
ure 3b and 3c). In addition, PAI expression level varied
among individual transformants carrying the same ex-
pression cassette (Figure 3).
PAI activity in Y. lipolytica
In this study, the conversion rate of LA into CLA repre-
sented PAI activity. According to the PAI expression
level, six represented transformants with best or average
performance in each series were selected for in vitro PAI
activity assay. In these selected transformants, PAI activ-
ities (Figure 4) was correlated with the expression level
Figure 2 Relative copy numbers of integrated expression cassettes in Yarrowia lipolytica multi-copy transformants. Real-time PCR was
used to estimate the copy number of the integrated expression cassettes among 13 Polh-1292-oPAI transformants. Y. lipolytica Polg was used as a
control organism with a single copy of both the URA3 and SUC2 target sequences. As URA3 and oPAI coexisted in expression cassette, the copy
numbers of both genes were considered as equal.
Figure 3 Western blot analysis of recombinant PAI and percentage of CLA of total fatty acids (w/w). (a) Western blot analysis of Polh-
1312-PAI transformants, (b) Western blot analysis of Polh-1312-oPAI transformants and (c) Western blot analysis of Polh-1292-oPAI transformants.
Numbers above the lines represents the individual transformants and control is the strain transformed with the empty vector pINA1312 or
pINA1292. Molecular size markers are indicated on the right. The standard deviations were <1% of the values shown.
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not shown). This phenomenon suggested that the ‘spe-
cific activities’ of PAI were comparable among the differ-
ent transformants. The maximal conversion rate of 80%
was obtained from transformant Polh-1292-oPAI-5. PAI
activities were undetectable in transformants Polh-1312-
PAI-2 and control strains (Polh-1312 and Polh-1292).
Production of CLA in Y. lipolytica
To detect the possible production of CLA in the PAI
transformants, lipid was extracted from these cells and
FAME products of the lipid were prepared. FAMEs were
qualitatively and quantitatively analyzed by GC and GC/
MS. The results shown in Figure 5 and Table 1 revealed
that there was no significant difference in the overall
fatty acid composition between transformants and con-
trol strains except for a new peak, which was present in
some transformants but not observed in control strains.
The newly produced FAME was identified as trans-10,
cis-12 CLA, comparing with authentic commercial stan-
dards. The identity of this CLA isomer was further veri-
fied by GC/MS (Figure 6).
In correspondence with the Western blot results,
trans-10, cis-12 CLA was detected in all yeasts trans-
formed with the optimized gene oPAI, but only in two
transformants with the native gene PAI (Polh-1312-PAI-
3 and Polh-1312-PAI-4). Besides, the CLA yields in indi-
vidual strains with same expression cassette varied
greatly as the PAI expression levels. The maximal
amount of CLA in the yeasts transformed with native
PAI was only 0.2% of total fatty acids (w/w). By contrast,
the concentrations of CLA in all mono-copy oPAI trans-
formants were above 0.2% with the maximal of 1.2%.
Moreover, the average CLA contents in the multi-copy
oPAI transformants were further increased to 3.4% and
the maximal CLA concentration reached 5.9% (Table 1).
Codon optimization of PAI resulted in a 6-fold increase
in the maximal production of CLA. With multi-copy in-
tegration being taken into account, the improvement
reached an approximately 30-fold increase over mono-
copy PAI transformants. Taken together, our Western
blot analysis, in vitro enzymatic activity assay and in vivo
CLA yields analysis results demonstrated that the
increased CLA yield was due to the enhanced expression
level of PAI in these yeast transformants.
Discussion
To date, the LA isomerase originating from P. acnes is
the only LA isomerase that has been thoroughly investi-
gated through biochemical characterization and crystal
structure analysis, and appears to be of potential biotech-
nological applications. However, as the only substrate of
PAI is free fatty acid, a minor component in most
microbes and plants, it is difficult to produce sufficient
trans-10, cis-12 CLA through genetic engineering of PAI.
Several studies have reported to produce CLA by bio-
logical processes, through introduction of PAI into
tobacco seed and rice, but the amount of CLA produced
in these transgenic plants was only 0.3% and 1.6% of the
total fatty acid amounts, respectively [12,13]. An appro-
priate biosynthesis system for CLA production has not
been found yet.
To address this problem, Y. lipolytica was chosen as
the host strain for PAI expression and CLA production
in this study. Y. lipolytica is currently the only oleaginous
yeast for which specific genetic tools have been devel-
oped and has ability to accumulate significant amounts
of free LA [15]. Our results demonstrated that trans-
formed Y. lipolytica could produce considerable amounts
of CLA, and the production of CLA was increased with
a multiple-copy expression of a codon-optimized gene.
In a previous study, PAI expression was improved in S.
cerevisiae after optimizing the 20 N-terminal amino acid
residues of PAI [12]. In our study, the full-length of the
Figure 4 Conversion rate of LA to CLA in selected Yarrowia lipolytica transformants. Six represented transformants were selected for in vitro
PAI activity assay. Polh-pINA1312 and Polh-pINA1292 were used as the control strains. PAI activity was represented by the conversion rate of LA to
CLA, and calculated by the ratio of [CLA]/([LA]+[CLA])×100%.
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optimization fundamentally enhanced PAI expression
(Figure 3) as the translation efficiency was promoted.
These results demonstrated that the optimization of
codon usage is important to enhance the expression of
prokaryotic gene in a eukaryotic host organism. Multi-
copy vector was also successfully used for the increased
production of many proteins in Y. lipolytica, a 10 to 20-
fold increase can be obtained over mono-copy integrants
[18]. In comparison with the mono-copy plasmid, the
amounts of expressed PAI in almost all multi-copy trans-
formants were greatly increased due to the gene dosage
effect (Figures 2 and 3). However, variation of PAI ex-
pression levels was also observed in different strains car-
rying similar copy numbers of the gene (Figures 2 and
3). A possible explanation for this phenomenon is that
some integration sites of the expression cassette in the
genome may affect the PAI production. Expression cas-
settes bound by the zeta regions have been found to ran-
domly integrate in the chromosome of Y. lipolytica Polh
lacking zeta regions [19]. This also indicates that it is ne-
cessary to screen as many transformants as possible to
isolate the ideal transformants.
The combined effects of codon-optimization and gene
amplification by using a multi-copy vector allowed us to
increase the CLA production by almost 30 times, which
is in agreement with the protein expression results. In the
present work, we analyzed lipid compositions of all the
transformants carrying the multi-copy cassettes. And the
maximal CLA amount reached 5.9% of the total fatty acid
yield in Y. lipolytica, which is much higher than that
found in transgenic tobacco seed and rice [12,13]. The
positive correlation between the protein expression level
and CLA yield also suggested that the expression level of
PAI was one of the key limiting factors for CLA produc-
tion. Therefore, optimization of the cultivation conditions
and genetic modifications will be carried out in the future
to further increase the yield of CLA in Y. lipolytica.
Conclusions
In this work, we have successfully constructed a de novo
CLA biosynthesis system by transforming the oleaginous
yeast strain, Y. lipolytica, with the recombinant linoleate
isomerase gene from P. acnes. The expression level of
PAI was dramatically increased by optimization of the
codon-usage of PAI in the yeast and increasing the copy
number of the gene using multi-copy vector. Coincide
with the increased recombinant protein level, the trans-
10, cis-12 CLA yield increased as well, with a 30-fold in-
crease compared to the mono-copy integrants carrying
native PAI. The best performed transformed yeast strain
could produce up to 5.9% of CLA of the total fatty acid
yield. The CLA yield in the transformed Y. lipolytica was
much higher than those found in the transgenic non-
oleaginous plants. Therefore Y. lipolytica should be con-
sidered as a CLA biological synthesis system of choice
for future industrial applications.
Figure 5 Gas chromatogram analysis of FAMEs from
transformed yeasts. FAMEs from yeasts transformed with empty
mono-copy vector pINA1312 (a), empty multi-copy vector pINA1292
(b), pINA1312-PAI (c), pINA1312-oPAI (d), pINA1292-oPAI (e), and
commercial CLA mixture (f) were analysis by GC. Heptadecanoic acid
(17:0) in the chromatograms was used as the internal standard
(ISTD).
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Chemicals, strains and culture media
Restriction enzymes were purchased from Takara Bio,
Inc (Takara, Dalian, China). The KOD plus DNA poly-
merase was purchased from Toyobo Co., Ltd. (Katada,
Ohtsu-shi, Shiga-ken, Japan) and fatty acid methyl ester
(FAME) standards were obtained from Sigma (Sigma,
Shanghai, China). Oligonuleotide primers and other
chemicals were supplied by Shanghai Sangon Biological
Engineer Technology & Service Co., Ltd. (Sangon,
Shanghai, China).
E. coli DH5α was used for routine subcloning and plas-
mid propagation. E. coli BL21 (DE3) was used for the
over-expression of recombinant protein for antibody
generation. The auxotrophic strain Y. lipolytica Polh [18]
was used as the PAI expression host, while Y. lipolytica
Polg was used as a control strain for real-time polymer-
ase chain reaction (RT-PCR). Y. lipolytica strains were
kindly provided along with the plasmids pINA1312 and
pINA1292 [17] by Prof. Catherine Madzak (Institut Na-
tional de la Recherche Agronomique/AgroParisTech,
France).
All E. coli strains were grown in Luria-Bertani broth
(LB) containing ampicillin (100 mg/ml) or kanamycin
(50 mg/ml) for plasmid selection. YPD and YNBD media
were prepared for Y. lipolytica as described previously
[20].
Plasmid construction, yeast transformation and gene
expression
Standard protocols were followed for DNA manipulation
[21]. In this study, the native and codon-optimized
Table 1 Fatty acid composition of five transformed strains
of Y. lipolytica
Polh-1312
(control)
Polh-1312-
PAI-4
Polh-1312-
oPAI-20
Polh-1292-
oPAI-5
Polh-1292
(control)
16:0 22.1±0.5 9.1±0.2 7.4±0.1 10.9±0.3 7.5±0.3
16:1(7c/9c) 9.2±0.2 10.2±0.3 12.0±0.3 12.7±0.3 12.6±0.5
17:1 1.9±0.0 2.7±0.1 2.3±0.1 2.7±0.1 2.5±0.1
18:0 0.12±0.0 0.3±0.0 0.2±0.0 0.4±0.0 0.2±0.0
18:1 42.4±1.4 48.2±1.5 51.8±1.3 49.0±1.1 59.1±1.6
18:2 24.4±0.6 29.2±1.0 25.1±0.7 18.5±0.4 18.1±0.8
10 t, 12c-
CLA
ND 0.2±0.2 1.2±0.03 5.9±0.1 ND
Values are represented at weight % of the total fatty acids of yeast
transformants. The means±SD were obtained from three independent
experiments. ND, not detected.
Figure 6 GC/MS analysis of fatty acid isolated from yeasts transformed with pINA1312-oPAI. (a) Shows gas chromatogram of FAMEs from
Polh-pINA1312-oPAI. (b) Shows mass spectrogram of trans-10, cis-12 CLA at 10.5 min in gas chromatogram (a).
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in Y. lipolytica. The native coding sequence (PAI) (Gene-
Bank AX062088), flanked with PmlI and KpnI, was amp-
lified by PCR using the primers P1 and P2 (sequences
see below) and template plasmid pGEX6-1-PAI, which
was kindly provided by Prof. Ivo Feussner (Georg-August-
University, Göttingen, Germany). Standard PCR consisted
of 30 cycles of 15 seconds at 94C, 30 seconds at 57C,
and 15 seconds at 68C.
P1: 5'-CACGTGATGTCCATCTCGAAGG-3';
P2: 5'-GGTACCTTACACGAAGAACCGC-3'.
Underlined nucleotides depict the restriction sites. The
codon-optimized sequence (oPAI) was designed accord-
ing to the codon preference of Y. lipolytica using the
Genscript OptimumGene
TM system. GCCACA was
added before the first methionine to create a Kozak se-
quence. The newly designed DNA sequence flanked with
PmlI and KpnI was synthesized (Genscript, Nanjing,
China). The two versions of DNA fragments digested
with the appropriate restriction enzymes were ligated to
form the mono-copy plasmids pINA1312-PAI and
pINA1312-oPAI, respectively. The vector pINA1292,
which carries a defective URA3 allele, ura3d4, for multi-
copy integration into the genome [17], was preferably
used for PAI over-expression in Y. lipolytica. The con-
struction of multi-copy plasmid pINA1292-oPAI was
performed following the same procedures used for the
case of pINA1312-oPAI described above. All newly con-
structed plasmids were screened by restriction enzyme
digestion and PCR, and then confirmed by DNA
sequencing.
Transformation was performed by the lithium acetate
method, as described previously [20]. Transformants
were selected by plating on YNBD. Real-time PCR (RT-
PCR) was used to estimate the copy number of the inte-
grated expression cassettes in Polh-1292-oPAI transfor-
mants according to the protocol described in [22]. Y.
lipolytica transformants were grown in YPD medium at
28C overnight. These pre-cultures were inoculated into
50 ml of YPD medium to an OD600 of 0.1 and further
cultured for another 72 h at 28C and 200 rpm. Cells
were collected by centrifugation (6000 g; 5 min) and
washed once with deionized water, and the pellet was ei-
ther directly used for Western blot analysis and in vitro
enzyme activity assay or lyophilized for biomass deter-
mination and lipid analysis.
Generation of PAI-specific polyclonal antibodies and
Western blotting analysis
His-tagged fusion PAI was produced in E. coli BL21
(DE3) and purified by nickel ion affinity chromatography
as described by Hornung et al. [12]. The purified His-
tag-PAI was used as antigen for the generation of specific
polyclonal antibodies in rabbits (AbMax Biotechnology,
Beijing, China). To confirm the recombinant PAI expres-
sion in Y. lipolytica, Western blot analysis was carried
out according to previously described methods [12].
Lipid extraction and fatty acid analysis
Lipids from the equivalent weight of freeze-dried cells
(50 mg) were directly transmethylated using the method
described by Sakuradani et al. [23]. Fatty acid methyl
esters (FAMEs) were analyzed by GC and GC/MS. GC
analysis was performed with a GC-2010 (Shimadzu Co.,
Japan) equipped with a FID detector and a capillary DB-
WAX column(30 m×0.32 mm, φ0.25 μm; Agilent,
USA). Helium was used as carrier gas (2 ml/min). The
samples were measured with a split of 15:1 with the in-
jector temperature set to 240C. The temperature gradi-
ent was 120C for 3 min, 120C–190C at 5C/min,
190C– 210C at 1C/min and 210C for 3 min. FAMEs
were identified by comparing with commercial FAME
standards (37 Component FAME Mix, Supelco, USA;
conjugated linoleic acid methyl ester, Sigma, USA) and
quantified by the internal standard method by adding
146 μg of commercial C17:0 (Sigma, USA). GC/MS ana-
lysis was carried out using a Varian 1200 L GC/MS-MS
equipped with a capillary DB-FFAP column
(30 m×0.25 mm, φ0.25 μm; Agilent, USA). Helium was
used as carrier gas (0.8 ml/min). The temperature gradi-
ent was 180C for 1 min, 180– 250C at 5C/min, 250C
for 21 min. The electron energy was set to 70 eV, and
the ion source temperature and transfer line temperature
were held at 200C and 260C, respectively.
In vitro enzymatic activity assay
Yeast cell pellets were re-suspended in Tris buffer
(100 mM Tris/HCl pH 7.5; 10 mM NaCl, 10% glycerol).
The soluble protein from the yeast cells were obtained as
described in [24]. A total of 8 mg soluble protein in 1 ml
Tris buffer were incubated for 1 hour at 37C with
800 μg LA. Fatty acid from the reaction system was
extracted, methylated as described previously [9] and
analyzed via GC described above. PAI activity was repre-
sented by the conversion rate of LA to CLA, and calcu-
lated by the ratio of [CLA]/([LA]+[CLA])×100%.
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